- Home
- AMPH vs LILAK Comparison
AMPH vs LILAK Comparison
Compare AMPH & LILAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPH
- LILAK
- Stock Information
- Founded
- AMPH 1996
- LILAK 2017
- Country
- AMPH United States
- LILAK Bermuda
- Employees
- AMPH N/A
- LILAK N/A
- Industry
- AMPH Biotechnology: Pharmaceutical Preparations
- LILAK Cable & Other Pay Television Services
- Sector
- AMPH Health Care
- LILAK Telecommunications
- Exchange
- AMPH Nasdaq
- LILAK Nasdaq
- Market Cap
- AMPH 1.1B
- LILAK 1.1B
- IPO Year
- AMPH 2014
- LILAK N/A
- Fundamental
- Price
- AMPH $25.52
- LILAK $5.15
- Analyst Decision
- AMPH Hold
- LILAK Buy
- Analyst Count
- AMPH 5
- LILAK 3
- Target Price
- AMPH $38.00
- LILAK $10.27
- AVG Volume (30 Days)
- AMPH 521.8K
- LILAK 1.8M
- Earning Date
- AMPH 05-07-2025
- LILAK 05-07-2025
- Dividend Yield
- AMPH N/A
- LILAK N/A
- EPS Growth
- AMPH N/A
- LILAK N/A
- EPS
- AMPH 2.77
- LILAK N/A
- Revenue
- AMPH $730,659,000.00
- LILAK $4,441,000,000.00
- Revenue This Year
- AMPH $0.65
- LILAK $3.30
- Revenue Next Year
- AMPH $5.26
- LILAK $3.11
- P/E Ratio
- AMPH $9.23
- LILAK N/A
- Revenue Growth
- AMPH 8.05
- LILAK N/A
- 52 Week Low
- AMPH $22.64
- LILAK $4.23
- 52 Week High
- AMPH $53.96
- LILAK $10.93
- Technical
- Relative Strength Index (RSI)
- AMPH 53.84
- LILAK 48.07
- Support Level
- AMPH $25.13
- LILAK $4.89
- Resistance Level
- AMPH $26.57
- LILAK $5.24
- Average True Range (ATR)
- AMPH 0.71
- LILAK 0.17
- MACD
- AMPH 0.17
- LILAK 0.03
- Stochastic Oscillator
- AMPH 62.90
- LILAK 44.07
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
About LILAK Liberty Latin America Ltd. Class C
Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.